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 45 
One Sentence Summary: We show that NETs contribute to the pathogenesis of 46 
malaria by promoting emergency granulopoiesis and facilitating cytoadhesion of 47 
parasitized erythrocytes to the endothelium.  48 
 49 
 50 
Abstract 51 
 52 
Neutrophils are essential innate immune cells that extrude chromatin in the form of 53 
neutrophil extracellular traps (NETs). This form of cell death has potent 54 
immunostimulatory activity. We show that heme-induced NETs are essential for 55 
malaria pathogenesis. Using patient samples and a mouse model, we define two 56 
mechanisms of NET-mediated inflammation of the vasculature: activation of 57 
emergency granulopoiesis via GCSF production, and induction of the endothelial 58 
cytoadhesion receptor ICAM-1. Soluble NET components facilitate parasite 59 
sequestration and mediate tissue destruction. We demonstrate that neutrophils have 60 
a key role in malaria immunopathology and propose inhibition of NETs as a treatment 61 
strategy in vascular infections.  62 
 3 
Introduction 63 
 64 
Neutrophils are the most abundant leukocytes in the blood and they respond to 65 
pathogens by phagocytosis, generation of oxidants and externalization of microbicidal 66 
peptides and proteases [1]. The release of these compartmentalized antimicrobials is 67 
achieved by either degranulation or the release of neutrophil extracellular traps (NETs). 68 
NETs consist of decondensed chromatin decorated with microbicidal and 69 
immunostimulatory molecules [2, 3]. NETs are released by a cell death program 70 
termed ‘NETosis’ and they ensure high local concentrations of active antimicrobials. 71 
Eventually, deoxyribonuclease 1 (DNase 1), a constitutive plasma endonuclease, 72 
degrades NETs and facilitates their removal [4]. 73 
 NETosis is an active process that requires microbial or mitogenic signaling [5, 74 
6], the production of reactive oxygen species (ROS) [7], the activity of two serine 75 
proteases: neutrophil elastase (NE) and proteinase 3 (PR3) [8, 9], and the activation 76 
of the pore forming protein gasdermin D [10]. NE translocates from the granules to the 77 
nucleus during NET induction, where it cleaves histones to allow chromatin 78 
decondensation prior to plasma membrane breakdown [8]. NE and PR3 have partially 79 
overlapping substrates [11] and are both required for maximal NET induction in vivo 80 
[9].  81 
Triggering of NETosis by various microbes in tissues or the mucosa limits 82 
pathogen proliferation and dissemination [12]. NET release inside the vasculature, 83 
however, can be pathogenic by triggering autoimmunity [13], as well as by directly 84 
damaging blood vessels [14, 15]  and inducing thrombosis [16]. 85 
To understand the role of neutrophils and NETs in intravascular infections, we 86 
investigated malaria, a disease caused by protozoan parasites that invade red blood 87 
cells (RBCs) and trigger systemic neutrophil activation [17, 18]. Plasmodium 88 
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falciparum is the most important and virulent species, causing over 200 million malaria 89 
episodes and close to 500,000 deaths annually [19]. It encompasses diverse 90 
pathological manifestations that can range from mild unspecific symptoms, fever and 91 
mild anemia to organ failure, acidosis, coma and death. Complications of severe 92 
malaria include coma, prostration, respiratory distress, metabolic acidosis, renal 93 
failure, liver damage and severe anemia [20, 21]. 94 
Pathogenesis of P. falciparum malaria is precipitated by its interaction with the 95 
vascular endothelium. In the second half of the asexual erythrocytic lifecycle, parasites 96 
express cytoadhesion factors on the surface of infected RBCs (iRBCs), allowing 97 
binding and sequestration in postcapillary venules. Attachment and withdrawal from 98 
circulation is thought to aid in preventing clearance of iRBCs by splenic macrophages 99 
[22]. Disease severity is synergistically determined by sequestration patterns and host 100 
inflammatory responses [23, 24]. Cytoadhesion of iRBCs leads to endothelial 101 
activation and vascular occlusion [24], while release of pathogen- or danger- 102 
associated molecular pattern (PAMP or DAMP) molecules leads to pathological 103 
inflammatory responses mediated by cytokines such as tumor necrosis factor (TNF) 104 
and interleukin (IL)-1β [25]. Organ-specific iRBC sequestration is associated with 105 
corresponding pathology [23, 24]. 106 
Despite the important inflammatory component of the disease, the role of 107 
neutrophils in P. falciparum malaria remains unclear. Neutrophils isolated from malaria 108 
patients have a reduced capacity to mount an oxidative burst [26]. On the other hand, 109 
several studies have linked activation of these cells to pathogenesis and severe 110 
disease [17, 18, 27]. For instance, a recent blood transcriptomic analysis comparing 111 
severe and uncomplicated malaria identified a granulocyte colony stimulating factor 112 
(GCSF)-regulated neutrophil granulopoiesis signature as a specific feature of severe 113 
malaria [18] . Granulopoiesis refers to production of neutrophils from progenitor cells 114 
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in the bone marrow; this blood signature therefore identifies increased neutrophil 115 
abundance as a pathogenic factor in malaria. Furthermore, genes encoding neutrophil 116 
granule proteins, such as NE and matrix metalloproteinase-8 (MMP-8), showed the 117 
highest upregulation between severe and uncomplicated malaria [18]. Similarly, a 118 
study in Malawi demonstrated that retinopathy-positive cerebral malaria is specifically 119 
associated with accumulation of externalized neutrophil proteins such as NE and PR3 120 
[17]. Several studies in mice have also linked neutrophils to severe malaria [28-31]. 121 
Notably, depletion of neutrophils with a specific antibody reduces pathology in 122 
Plasmodium chabaudi chabaudi mouse infections [28]. 123 
In addition to the accumulation of soluble neutrophil proteases, severe disease is 124 
associated with an increase in extracellular human nucleosomes in patients’ plasma 125 
[32], which could indicate NET release. NETs are a platform for externalizing both 126 
nucleosomes and neutrophil proteases and could thus be an important pathogenic 127 
factor in malaria. Indeed, NETs were reported in mouse malaria [31] and NET-like 128 
structures were observed on patient blood smears [33, 34].  129 
We show, using patient samples, that NETs are triggered by extracellular heme 130 
in malaria. We found NETs to be a source of immunostimulatory molecules - alarmins 131 
- that activate emergency hematopoiesis via GCSF induction. In the P. chabaudi 132 
mouse model, host DNase 1 liberated neutrophil proteins from NETs and this release 133 
was required for neutrophilia and neutrophil infiltration in the liver. Soluble NET 134 
components were also required for parasite sequestration in liver and lung. Genetic 135 
depletion of NETs, or NET-processing DNase 1, reduced organ damage. We 136 
demonstrate an undescribed physiological role for NETs in circulation, as well as 137 
identify a potential target for adjunctive malaria therapy. 138 
 139 
 140 
 6 
Results 141 
Intravascular NET formation in P. falciparum malaria 142 
To test if P. falciparum malaria is accompanied by bona fide NET induction, we 143 
initially analyzed plasma samples from forty-three parasitologically confirmed pediatric 144 
and adult patients, treated at the Albert Schweitzer Hospital, in Lambaréné, Gabon, a 145 
highly malaria-endemic region in Central Africa. The patients presented with variable 146 
symptoms such as hyperparasitemia, fever and anemia (Table S1) but did not show 147 
severe symptoms, and all recovered upon antimalarial treatment. NETs are defined as 148 
complexes of chromatin and neutrophil granule proteins; hence, we used an ELISA 149 
that detects NETs with an anti-DNA detection antibody, preceded by a capture 150 
antibody against NE.  Malaria patients had significantly elevated levels of NETs  151 
compared to healthy controls from the same region (n = 9) (Fig. 1A).   152 
To test if NETs are linked to malaria severity we next measured NE-DNA complexes 153 
in plasma from two different patient cohorts, each consisting of uncomplicated and 154 
severe malaria. The first cohort again consisted of pediatric patients from Lambaréné, 155 
Gabon, recruited in 1995 and 1996 as part of a case-control study with a subsequent 156 
longitudinal survey comparing severe (n=23) with strictly defined uncomplicated 157 
malaria cases (n=10; Table S2). Most children had severe anemia or hyperparasitemia 158 
and other complications; mortality was 3% [35]. The second cohort were 28 159 
uncomplicated and 27 severe malaria HIV-negative adult in-patients at Central 160 
Hospital in Maputo, Mozambique. Severe malaria in this cohort was defined according 161 
to the severity criteria developed by the World Health Organization [36] and included 162 
cerebral malaria (CM), respiratory distress, liver failure and severe anemia (Table S2). 163 
In both cohorts NETs were significantly enriched in severe versus uncomplicated 164 
malaria (Fig. 1B and C).  165 
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We also isolated peripheral blood neutrophils from hospitalized adult patients and 166 
monitored NET formation. Neutrophils from malaria patients (n = 8) released twofold 167 
more NETs than healthy controls (n = 6) (Fig. 1D). Importantly, NETs were released 168 
without the addition of exogenous stimuli, indicating that NETosis in malaria is 169 
activated in vivo. 170 
To further demonstrate NETs in vivo and to examine their association with 171 
neurovascular sequestration of infected red blood cells (iRBCs), a key event in CM 172 
pathogenesis, we examined retinal tissue from fatal paediatric cases who had died 173 
with a clinical diagnosis of cerebral malaria. Retinopathy is a highly specific feature of 174 
CM [37], and pathological changes in the retinal vasculature in CM are representative 175 
of those in the cerebral microvasculature [38, 39]. Through post mortem examination, 176 
cases were divided into those who had sequestration of parasitized erythrocytes in 177 
the brain and no alternative cause of death and were deemed to have ‘true’ CM, and 178 
those who had no sequestration and were in fact all found to have alternative causes 179 
of death. This second “faux CM” group is a useful comparator group to control for the 180 
effect of fatal encephalopathy and premorbid events versus those that are due to 181 
parasite sequestration. We analysed the retinas of nine definitive CM cases and eight 182 
comatose malaria cases without retinopathy (Table S3) and identified NETs by co-183 
localization of citrullinated histone H3, elastase and DAPI. As expected, most of the 184 
retinal capillaries in true CM cases were packed with sequestered parasitized RBCs 185 
(Fig 1E). NETosis was detected exclusively in retinopathy positive CM cases (9/9) 186 
and localized only to areas with parasitized RBCs (Fig. 1F and G). Z-stack imaging 187 
revealed that NETs filled the lumen of retinal capillaries (Fig. 1G), enveloping the 188 
parasitized erythrocytes. Together, these data demonstrate that NETs are induced in 189 
the vasculature of malaria patients and that this correlates with parasite 190 
sequestration and disease severity. 191 
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NETs in malaria are induced by heme and TNF 193 
To identify factors that trigger NET formation in malaria, we co-incubated neutrophils 194 
from healthy adult donors with P. falciparum cultures. Neutrophils were either primed 195 
with TNF, a major malaria-associated proinflammatory cytokine [24], or left unprimed. 196 
We exposed neutrophils to iRBCs, free merozoites, parasite digestive vacuoles, which 197 
are released upon RBC rupture and contain the hemozoin crystal, as well as heme, a 198 
known malaria DAMP that is released during parasite egress, as well as during 199 
‘bystander hemolysis’ – the inflammatory destruction of uninfected RBCs [25, 26]. 200 
Interestingly, only heme robustly induced NETs in combination with TNF priming (Fig. 201 
2A & S1A), as previously reported in sickle cell disease [40].  202 
 To verify that NET formation is linked to hemolysis in vivo, we determined the 203 
plasma free heme concentrations in our patient cohorts and examined their 204 
association with plasma NE-DNA complexes. We found that free heme positively 205 
correlates with circulating NETs in both Gabon cohorts (Fig. 2B and C) but not in the 206 
adult Mozambique patients (Fig. 2D), possibly due to some very high heme values in 207 
the latter. Consequently, we incubated neutrophils from healthy donors with plasma 208 
from patients to test if soluble factors are sufficient to induce NETs. Plasma from 209 
severe, but not mild malaria was sufficient to induce NETs in healthy neutrophils and 210 
this effect was abolished by the heme scavenger hemopexin (Fig. 2E). In summary, 211 
accumulation of free heme during malaria activates neutrophils to release NETs. 212 
 213 
Heme-induced NETs require oxidants and NE/PR3 mediated proteolysis 214 
There are different pathways leading to NET formation [41]. We tested the 215 
involvement of host factors previously implicated in NETosis, starting with the ROS-216 
producing enzyme NOX2 [7].  We isolated neutrophils from patients with chronic 217 
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granulomatous disease (CGD) (n=3), who carry NOX2 mutations, rendering them 218 
completely deficient in ROS production (Fig S1C). Heme induced similar levels of 219 
NETs in CGD and control neutrophils, unlike the phorbol ester PMA, which failed to 220 
induce NETs in CGD cells (Fig 2F). Although this oxidase was not involved, heme-221 
induced NETs required ROS signaling since treatment with the ROS scavenger 222 
pyrocatechol (Fig S1C) completely abolished NETosis (Fig 2G), suggesting that heme 223 
itself might be the oxidizing agent. The requirement for ROS was confirmed with a 224 
second scavenger, N-acetyl cysteine (NAC; Fig. S1E). Heme required intracellular 225 
oxidant production, since a combination of two non-cell permeant scavengers, catalase 226 
and superoxide dismutase, failed to block NETs, as did a scavenger of mitochondrial 227 
ROS (Fig. S1E). 228 
In addition to oxidants, heme-triggered NETs required activity of protein kinase C 229 
(PKC) [42], cyclin dependent kinase 6 (CDK6) [5], and NE/PR3 [9] but were 230 
independent of peptidyl arginine deiminase 4 (PAD4)-mediated citrullination [43] (Fig 231 
2G). We also tested the requirement for de novo protein synthesis using the 232 
translational inhibitor cycloheximide. This drug, at a concentration that fully blocked 233 
synthesis of the cytokine IL-8 (Fig. S1B), had no effect on NET formation (Fig 2G), as 234 
previously reported for other NET stimuli [44]. 235 
To genetically confirm the role of proteases in heme NET induction, we purified 236 
peritoneal neutrophils from NE single and NE/PR3 double knockout mice. NE/PR3 -/- 237 
neutrophils failed to release extracellular chromatin, while NE -/- cells displayed a 238 
partial deficiency (Fig. 2H & I), demonstrating that these proteases have an essential 239 
non-redundant function in decondensing chromatin. In contrast, there was no 240 
difference in NET formation between PAD4 -/- and control neutrophils (Fig 2H & I).  241 
 242 
NET fragments drive malaria pathology in vivo 243 
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To address the function of NETs in Plasmodium infections in vivo, we used NE/PR3  244 
-/- mice as a NET deficient model. Additionally, to investigate the effect of a failure to 245 
degrade NETs extracellularly we used DNase 1 -/- mice. In the absence of DNase 1, 246 
NETs are made normally (Fig. 2H & I) but they persist at sites of release because they 247 
are not processed into soluble components [4]. DNase 1 -/- animals are deficient in 248 
dispersal of NET components and are a model to study the systemic effects of NET-249 
associated alarmins. 250 
We infected mice with the erythrocytic stages of P. chabaudi, a rodent malaria 251 
parasite that causes a non-lethal, two-week acute infection. Similarly to P. falciparum, 252 
P. chabaudi iRBCs synchronously sequester in organs and induce pathology [45, 46], 253 
although the sequestration pattern differs and cytoadhesion is mediated by different 254 
parasite-encoded proteins in the two species. We quantified NETs in plasma by 255 
detecting soluble complexes of DNA and the granule protein myeloperoxidase (MPO). 256 
We chose MPO over NE in order to enable us to analyze NETs in NE deficient mice. 257 
NET components (Fig 3A) and extracellular nucleosomes (Fig. 3B) increased in 258 
infected WT mice but were completely absent in NE/PR3 and DNase 1 -/- mice. This 259 
result is consistent with a failure to produce NETs in the case of NE/PR3 -/- animals 260 
and with a failure to break down the NET macrostructure in the case of DNase 1 -/-.  261 
Notably, parasitemia was similar in all three mouse strains (Fig. 3C), showing that 262 
NETs are not antiparasitic. As previously described [28, 45],  parasitemia peaked 263 
between day 9 and 11 and was suppressed by day 13 post infection. 264 
P. chabaudi sequesters in the liver and lungs where it induces tissue damage and 265 
immunopathology [45]. Livers from WT mice were severely darkened and discolored 266 
because of the accumulation of hemozoin and hepatocyte death (Fig. 3D). 267 
Remarkably, livers of infected NE/PR3 -/- and DNase 1 -/- mice were completely 268 
unaffected and indistinguishable from uninfected controls (Fig. 3D). Livers of WT, but 269 
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not NE/PR3 or DNase1 -/- mice, showed necrosis and immune infiltration, 270 
characteristic malaria pathology, upon histological analysis of haematoxylin and eosin 271 
(H&E) stained sections (Fig. 3E and Fig. S2A and B). We confirmed the liver pathology 272 
in wild type, but not mutant mice, with the hepatic damage marker asparate 273 
aminotransferase (AST) in plasma (Fig. 3F). Tissue damage was also reduced in lungs 274 
of NE/PR3 knockout mice (Fig. S3) compared to WT controls, although P. chabaudi 275 
causes only mild lung pathology [45].  Altogether, these data demonstrate that release 276 
of components from NETs promotes organ pathology in malaria. 277 
 278 
Exogenous NET components restore pathology in NET-deficient mice 279 
To confirm that NETs are pathogenic in malaria, we injected mice with in vitro 280 
generated NET fragments. We chose NE/PR3 -/- as the NET-deficient strain in which 281 
to carry out this complementation experiment. We first purified peritoneal neutrophils 282 
from WT mice and induced them to form NETs. After washing, NETs were dislodged 283 
by scraping and sonicated to obtain fragments, which were quantified based on DNA 284 
content and injected into the tail vein of control and P. chabaudi parasitized mice. 285 
Injection of NET fragments did not cause liver pathology in uninfected mice (Fig 3G) 286 
nor affect parasitemia in any of the infected genotypes (Fig. S4). Strikingly, restoring 287 
NET fragments in parasitized NE/PR3 -/- mice fully recapitulated the liver damage 288 
observed in WT mice (Fig 3G). This result demonstrates the direct pathogenicity of 289 
NETs and rules out a cell-intrinsic effect of proteases as the cause of the protective 290 
effect in the knockout animals. 291 
NETs contain multiple components with inflammatory activity [47]. These include 292 
the DNA backbone, as well as the protein fraction that contains many alarmins. 293 
Furthermore, extracellular nucleosomes and histones, which form a major portion of 294 
NETs, are inflammatory when found in the blood stream [48]. To identify which NET 295 
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components are responsible for inducing pathology, we used recombinant DNase 1 to 296 
fully digest the DNA of the in vitro NET preparation, leaving only the protein 297 
components. Notably, the NET protein fraction was sufficient to induce liver damage 298 
in NE/PR3 null mice (Fig 3G). As a control, we also injected mouse nucleosomes 299 
purified from bone marrow derived macrophages, which failed to induce AST release 300 
after injection (Fig 3G). These data show that the pathogenic activity derives from a 301 
NET-associated protein .  302 
 303 
NETs induce emergency granulopoiesis via GCSF induction 304 
Neutrophils cause tissue destruction due to the cytotoxic molecules they carry. We 305 
quantified neutrophil infiltration into the livers of parasitized mice using 306 
immunofluorescence staining of the intracellular neutrophil marker calgranulin A. 307 
Neutrophils accumulated in the livers of WT, but not NE/PR3 and DNase 1 -/- animals 308 
(Fig 4A and Fig. S5), consistent with neutrophils being initiators of hepatic pathology.  309 
We quantified systemic neutrophil numbers to determine why both deficient mice 310 
genotypes failed to recruit neutrophils into the liver. In malaria, like other infections, the 311 
number of circulating neutrophils increases due to emergency granulopoiesis in the 312 
bone marrow [49-51]. We observed that P. chabaudi infection leads to neutrophilia in 313 
WT mice but not in NE/PR3 and DNase1 knockouts (Fig 4B). 314 
The major mediator of emergency granulopoiesis is GCSF [52]. We speculated that 315 
NETs directly induce GCSF. To test this, we stimulated macrophages – a significant 316 
physiological source of this cytokine - with NETs in vitro. NETs robustly induced 317 
production of GCSF in human monocyte-derived macrophages, at levels similar to 318 
those obtained with bacterial lipopolysaccharide (LPS) and exceeding those obtained 319 
with TNF or hemozoin (Fig 4C). 320 
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In P. chabaudi infected WT mice, the concentration of GCSF in plasma increased 321 
with rising parasitemia; however, there was no increase in either NE/PR3 or DNase 1 322 
-/- mice (Fig 4D). To directly demonstrate that NETs induce GCSF in vivo, we injected 323 
sonicated NETs as described before. Injection of NET fragments fully restored GCSF 324 
production in NE/PR3 mice to levels seen in WT mice (Fig 4E). As with the liver 325 
damage marker AST, GCSF production was induced by the protein component of 326 
NETs, as complete removal of DNA prior to injection did not abrogate the effect. These 327 
data show that NET-associated alarmins drive emergency hematopoiesis by inducing 328 
GCSF release. 329 
 330 
NETs promote parasite sequestration in organs 331 
Malaria pathology is linked to parasite sequestration in the microvasculature of afflicted 332 
organs. The lack of discoloration in livers of infected NE/PR3 and DNase 1 -/- mice 333 
(Fig 3D) suggests a lack of parasite adhesion. To directly analyze sequestration, we 334 
infected mice with a luciferase-expressing strain of P. chabaudi [45] and quantified 335 
sequestered parasite load in organs, at time of maximal cytoadhesion, after perfusing 336 
animals to remove unbound, freely-circulating parasites.  337 
As reported, P. chabaudi sequestered most prominently in the liver and the lung and, 338 
to a lesser degree, in the kidneys [45]. Remarkably, there were tenfold fewer 339 
parasites sequestered in the livers and lungs of NE/PR3 and DNAse 1 -/- mice 340 
compared to WT controls (Fig 5A). We confirmed this sequestration pattern by 341 
histological enumeration of iRBCs in the liver microvasculature (Fig. 5B and Fig. 342 
S2B) as well as by electron microscopy (Fig. S2C). 343 
 344 
NETs induce upregulation of endothelial cytoadhesion receptors 345 
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The difference in abundance of neutrophils in livers of WT and knockout animals was 346 
greater than the difference observed in peripheral blood, indicating that, in addition to 347 
emergency granulopoiesis, NETs regulate neutrophil trafficking. Interestingly, both 348 
neutrophils [53] and parasites [54, 55] can use the same receptor to dock to 349 
endothelial cells: intercellular adhesion molecule 1 (ICAM-1). We hypothesized that 350 
NET components regulate expression of ICAM-1 on the endothelium. To test this, we 351 
analysed ICAM-1 immunofluorescence in liver sections and observed upregulation 352 
on endothelia of infected WT but not NE/PR3 or DNase1 -/- mice, coinciding with the 353 
onset of liver damage (Fig. 5C and D). We also measured soluble ICAM-1 in plasma 354 
as an additional readout for expression of this receptor, and found no induction in 355 
NE/PR3 -/- compared to WT animals (Fig. 5E), confirming our microscopy results. 356 
Injection of in vitro generated NET fragments into parasitized NE/PR3 -/- mice 357 
restored the expression of ICAM-1 (Fig. 5E), demonstrating that NET components 358 
control ICAM-1 expression.  359 
Parasitized erythrocytes can bind to multiple endothelial surface proteins. 360 
Another prominent cytoadhesion receptor is CD36 [56]. We tested if NETs control 361 
expression of CD36 by microscopically analyzing protein abundance in lung 362 
endothelia. Similarly to ICAM-1, CD36 immunofluorescence increased in lungs of 363 
infected mice and this induction was absent in NE/PR3 -/- animals (Fig. 5F). We 364 
confirmed this result by quantifying levels of CD36 in plasma (Fig. 5G). Interestingly, 365 
and contrary to what we observed with ICAM-1, injection of NETs into uninfected 366 
mice was sufficient to upregulate CD36 (Fig 5F). In summary, NET-associated 367 
proteins facilitate iRBC sequestration by inducing endothelial activation. 368 
 369 
Neutralizing GCSF antibodies decrease liver damage  370 
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To test whether GCSF-induced neutrophilia is pathogenic, we neutralized the effects 371 
of this cytokine by injected parasitized animals with an anti-GCSF antibody, at day 7 372 
post infection. As expected, the neutralizing antibody did not impact parasite burden 373 
(Fig. 6A) but it decreased circulating neutrophils compared to the isotype control (Fig. 374 
6B). This also significantly reduced circulating NET components (Fig 6C), as well as 375 
neutrophil trafficking into the liver (Fig. 6D). GCSF neutralization diminished both 376 
parasite sequestration (Fig. 6E) and liver damage (Fig. 6F), providing a proof of 377 
principle that neutrophils can be successfully targeted in Plasmodium infection. 378 
Notably, the GCSF concentration in plasma of malaria patients is significantly 379 
increased in infected individuals (Fig 6G), as previously reported [57].   380 
 381 
Discussion 382 
 383 
Malaria pathophysiology is based on an interplay of parasite proliferation, host 384 
inflammatory response and microvascular obstruction due to binding of iRBCs to 385 
activated endothelia. Despite important recent advances [17, 18, 58], the contribution 386 
of neutrophils to these processes remains poorly understood. Here we demonstrate 387 
that neutrophils play an essential role in both propagation of inflammation and 388 
facilitation of parasite cytoadherence. 389 
Firstly, we showed that in malaria, as in sickle-cell disease [40], extracellular heme 390 
triggers NETosis in TNF-primed neutrophils. Heme-induced NETs require some of 391 
the same signaling intermediates demonstrated for other NET inducers, including 392 
neutrophil proteases [8], CDK6 [5] and PKC [42]. Heme was previously shown to 393 
activate PKC in neutrophils, initiating chemotaxis and IL-8 production [59]. TNF 394 
priming provides a synergistic signal required for NETosis; this signal is 395 
posttranslational, since it is not blocked by the translational inhibitor cycloheximide. 396 
Heme-induced NETs are independent of the citrullinating enzyme PAD4, which is 397 
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implicated in ionophore-induced NETs [43] and of the oxidant-generating enzyme 398 
NOX2 [41], which is known to be suppressed in neutrophils from malaria patients 399 
[26]. ROS signaling is nevertheless required for heme NETs, as the response is 400 
blocked by the ROS scavenger pyrocathecol. This may be due to the fact that heme 401 
is itself a redox-active molecule, with multiple mechanisms for initiating and 402 
propagating free radicals [60]. In summary, heme utilizes a unique pathway for NET 403 
induction that nevertheless requires both protease activity and ROS signaling. 404 
NETs are essential for malaria pathology in the P. chabaudi model. We showed 405 
that solubilization of NETs by serum Dnase1 liberates immunostimulatory 406 
components that diffuse systemically and are pathogenic via two mechanisms. The 407 
first is induction of GCSF in macrophages, which initiates emergency granulopoiesis. 408 
This corresponds to what is seen in patients, where GCSF is elevated in both P. 409 
falciparum [57] and P. vivax infections [61]. Moreover, neutrophil turnover is often 410 
higher in malaria [49-51] and, in children living in endemic areas, increased 411 
neutrophil counts correlate with symptoms of severe disease, such as prostration, 412 
coma and respiratory distress [62-64]. In a second mechanism, NET components 413 
upregulate mouse ICAM-1, a key cytoadhesion receptor that sequesters parasitized 414 
RBCs in the microvasculature of both mice and patients [54, 55]. Interestingly, in P. 415 
falciparum malaria, ICAM-1 mediates cytoadhesion in the brain and is a key mediator 416 
of cerebral malaria [55, 65]. Antibodies against ICAM-1 binding variants of P. 417 
falciparum Erythrocyte Membrane Protein 1 (PfEMP1), the main parasite 418 
cytoadhesion factor, protect against clinical disease [66, 67]. NET induction of ICAM-419 
1, which facilitates P. chabaudi adhesion in the liver, may thus operate in human 420 
malaria to recruit P. falciparum iRBCs to the brain, a far more dangerous 421 
sequestration site. This is consistent with recent reports showing an association 422 
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between neutrophil proteins and cerebral malaria [17, 18]. Whether NETs can also 423 
upregulate ICAM-1 on human brain endothelium remains to be verified. 424 
NET components are also required for pathology and parasite sequestration in the 425 
lungs of infected animals, demonstrating that this mechanism may be broadly 426 
generalizable to different vascular beds. Furthermore, in the P. chabaudi model, lung 427 
sequestration is mediated by an unidentified receptor other than ICAM-1 [54], 428 
consistent with NET components inducing more than one cytoadhesion molecule. It 429 
will be interesting to test if a similar mechanism operates in humans, since 430 
neutrophils are known to infiltrate the lungs of malaria patients with acute respiratory 431 
distress [68]. 432 
Our data demonstrate the essential role of DNAse 1 in releasing pathogenic NET 433 
fragments in P. chabaudi malaria. NETs are thought to be anchored to the 434 
endothelium after release [69, 70], through von Willebrand factor [69] and probably 435 
other mediators.  Serum DNAse 1 allows systemic diffusion of NET components, as 436 
demonstrated by absence of NET fragments in DNase 1 knockouts. A similar 437 
pathogenic function of DNAse 1 was shown in a polymicrobial sepsis model, where 438 
injection of recombinant DNase 1 promotes liver damage and neutrophil 439 
accumulation in liver and lung [71].  However, DNase 1 has contradictory roles in 440 
inflammation: in thrombosis [72, 73], cancer [74] and SLE [4], this endonuclease is 441 
protective rather than pathogenic. In sterile inflammation it is therefore the 442 
unprocessed NET ‘macrostructure’ that is detrimental, while in infections such as 443 
malaria and sepsis, it is the discrete molecular components of NETs that cause 444 
disease.  445 
The NET proteins that induce GCSF and ICAM-1 remain unknown. Many 446 
proteins found on NETs are classified as alarmins [75]; including α-defensins, 447 
cathelicidin, calgranulin and lactoferrin [76]. Once released, these alarmins can 448 
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induce the maturation and activation of dendritic cells, T cells, macrophages and 449 
endothelial cells [75]. Additional experiments will determine which NET-bound 450 
proteins are responsible for triggering granulopoiesis and endothelial activation.  451 
NET-associated molecules are necessary but not sufficient to drive inflammation 452 
in P. chabaudi malaria, as shown by the injection of NET fragments into uninfected 453 
mice. Additional stimuli, most likely Plasmodium PAMPs, are required to initiate 454 
emergency hematopoiesis and liver damage. Although parasite proteins and 455 
hemozoin did not directly induce NETs, they are known to significantly contribute to 456 
immune activation via other pathways [25] . Furthermore, inflammation in malaria is 457 
complex, with type-I interferons [28], CD8+ T cells [21, 45] and hemostasis [77] 458 
contributing to immunopathogenesis in both mice and humans. Further investigation 459 
is required to understand how neutrophils cross talk with other cell types in initiating 460 
disease. 461 
Malaria exerts an evolutionary selective pressure on populations living in endemic 462 
areas, selecting for gene variants that promote tolerance [78]. Interestingly, people of 463 
African descent and some ethnic groups from the Middle East, have low neutrophil 464 
counts [79]. This “ethnic or benign neutropenia” could be the result of selective 465 
pressure to suppress neutrophil counts since they are detrimental in this disease. 466 
Strikingly, in addition to Duffy antigen, the loci linked to ethnic neutropenias include  467 
CDK6 and GCSF [80], both of which are directly involved in the NET-mediated 468 
pathogenic mechanism described here. 469 
Recent studies confirmed the central role of heme in the pathophysiology of 470 
malaria [81, 82]. Moreover, extracellular heme accumulation is not limited to malaria; 471 
it is a confirmed pathogenic factor in sepsis, sickle cell disease, intracerebral 472 
hemorrhage and atherosclerosis [60], all of which also have reported neutrophil 473 
involvement. It will therefore be interesting to examine if emergency hematopoiesis 474 
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and endothelial activation triggered by NET fragments are universal outcomes in 475 
intravascular hemolytic diseases. 476 
Adjunctive therapies that treat the life-threatening complications of malaria are 477 
urgently needed. We show that NETs control inflammation and parasite 478 
cytoadherence, placing neutrophils at the nexus of malaria pathophysiology and 479 
identifying them as a potential target for adjunctive therapy. 480 
  481 
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Materials and Methods 482 
 483 
Human samples 484 
Our study was conducted in accordance with the Helsinki Declaration. Blood 485 
collection from healthy donors and CGD patients was approved by the ethical 486 
committee of Charité University Hospital, Berlin, Germany. Collection of blood from 487 
malaria patients in Gabon was approved by the Comité d'Ethique Régional 488 
Indépendent de Lambaréné in Gabon. All study participants provided written 489 
informed consent before being enrolled in the study. 490 
Collection of blood samples from patients in Mozambique was approved by the 491 
Bioethical Committee in Mozambique and by the Regional Ethical Committee for 492 
Medical and Health Research Ethics in Eastern Norway. This study was previously 493 
described [83] and consisted of patients admitted to the Central Hospital of Maputo, 494 
Mozambique during two malaria peak seasons, from 2011 to 2012. Inclusion criteria 495 
were age ≥ 18 years, non-pregnancy, axillary temperature ≥ 38 °C, confirmed malaria 496 
infection, and informed written/fingerprint consent from patient or next of kin. 497 
Ethical approval to obtain, store and use post-mortem human tissue from Malawian 498 
children with fatal cerebral malaria and non-CM encephalopathy was obtained from 499 
the research ethics committees at the College of Medicine Malawi, Liverpool School 500 
of Tropical Medicine and Michigan State University. Informed consent was obtained 501 
from the parents or legal guardians of all the children enrolled. 502 
 503 
Chemicals and stimuli 504 
 505 
PMA (P8139, Sigma), Heme (H651-9, Frontier Scientific), murine TNF (315-01A, 506 
Peprotech), human TNF (300-01A, Peprotech), PKC inhibitor (Go6976, Tocris), 507 
pyrocatechol (C9510, Sigma), Hoechst (639, Immunochemistry), cycloheximide 508 
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(Sigma), Cdk4/6 inhibitor (LY2835219, Selleck), PAD4 inhibitor (TDFA, Tocris), NE 509 
inhibitor (GW311616A, Sigma-Aldrich), Luminol (11050, AAT-Bioquest), horse radish 510 
peroxidase (HRP, 31941, Serva), Bright-Glo Luciferase Substrate (E2610, Promega) 511 
 512 
Immunofluorescence microscopy on human retinal tissue 513 
Paraffin sections (3–4 µm thick) were deparaffinised in two changes of xylene 100% 514 
for 5 minutes each and then hydrated in two changes of 100% ethanol for 5 minutes 515 
each, 90% and 70% ethanol for 1 minute each. For antigen retrieval UNI-TRIEVE 516 
(Universal Mild Temperature Retrieval Solution) was used to incubate the slides at 517 
60oC for 30 minutes. Afterwards slides were rinsed in PBS and blocked with Normal 518 
Horse serum for 30 minutes. Serum was removed and sections were incubated with 519 
primary antibody at appropriate dilution (1:200) in Normal Horse serum overnight at 4 520 
°C. Sections were rinsed in PBS Tween and then incubated with secondary antibody 521 
at appropriate concentration (1:400) for ~30 minutes in the dark and then rinsed in PBS 522 
Tween for 3 x 5 min before mounting with a DAPI containing medium (VECTASHIELD 523 
Antifade Mounting Medium with DAPI Cat. No: H-1200, Vector) which counterstains 524 
the nuclei. Primary antibodies for detection of NETs were: Neutrophil Elastase 525 
Antibody (G-2), (sc-55549; Santa Cruz) and Anti-Histone H3 Antibody (citrulline R2 + 526 
R8 + R17) (ab5103; Abcam). Secondary antibodies were: Goat Anti-Rabbit IgG H&L 527 
Alexa Fluor® 488 (Abcam; ab150081) and Goat Anti-Mouse IgG H&L Alexa Fluor® 528 
594 (Abcam; ab150116).  529 
Inverted Widefield Microscope (WF1-Zeiss) with LED illumination Zeiss Axio Observer 530 
and the highly sensitive Hamamatsu Flash 4 camera were used for fluorescent 531 
imaging. Z-stack images were collected at 63X magnification. Fiji and ICY [84] were 532 
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used for 3D visualization of z stack images. Huygens software was used for 533 
deconvolution of z-stack images.  534 
NETs ELISA  535 
NETs in plasma were determined as NE/DNA complexes in human samples and 536 
MPO/DNA complexes in mouse samples. For the human ELISA we used the 537 
precoated and blocked plates of the Hycult human NE ELISA (HK319-02). Undiluted 538 
plasma samples (50 µl)  were incubated for 2h at room temperature with 350 rpm 539 
agitation and washed three times with PBS-0.05% Tween (PBS-T). The anti-DNA-POD 540 
antibody (Cell Death Detection ELISA Kit, Roche) was diluted 1:100, and the plate was 541 
incubated for 2h at room temperature, followed by five washes with PBS-T and 542 
incubation with TMB substrate. Signal was acquired at 450 nm.  543 
For the mouse ELISA, the biotinylated primary mouse anti-MPO antibody (1µg/ml final 544 
concentration, HM1051BT, Hycult ) was coated onto a streptavidin coated plate from 545 
the Cell Death Detection ELISA Kit (Roche) at 4°C overnight, followed by three washes 546 
with PBS-T. The plates were subsequently blocked for 2h with 1 % BSA in PBS and 547 
50 µl undiluted mouse serum was added to wells. The plate was incubated for 2h at 548 
room temperature with agitation (300 rpm on a plate shaker), followed by three washes 549 
with PBS-T and addition of 50 µl per well of anti-DNA-POD from Roche cell death 550 
ELISA kit (1:100). The plate was incubated for two hours with agitation at room 551 
temperature, washed five times with PBST and developed with ABTS. 552 
 553 
 554 
ELISA Kits 555 
The following kits were used for plasma quantifications, according to manufacturer’s 556 
instructions: Cell Death Detection ELISA Plus (11920685001, Roche Diagnostics), 557 
Human Interleukin 8 Quantikine ELISA (S8000C, R&D Systems), mouse GCSF 558 
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Quantikine ELISA (MCS00, R&D Systems), human GCSF Quantikine ELISA (SCS50, 559 
R&D Systems), mouse ICAM-1 ELISA (DY796, R&D Systems), mouse CD36 ELISA 560 
(EMCD36, ThermoFisher) 561 
 562 
Human neutrophil isolation and stimulation  563 
Cells were purified by a first centrifugation of whole blood over Histopaque-1119 564 
(Sigma) followed by a discontinuous Percoll (Sigma) gradient [85]. All experiments 565 
were done in RPMI-1640 (w/o phenol red, Gibco) supplemented with 10mM HEPES 566 
and 0.05% human serum albumin (Albutein, Grifols). For NET induction, 105 567 
neutrophils were seeded onto glass coverslips in a 24 well plate and incubated with 568 
inhibitors for 30 min, followed by 15 min priming with TNF and addition of the stimuli.  569 
 570 
Luminol assay  571 
To assess ROS production, 1x105 neutrophils were activated (after treatment with 572 
inhibitors/ROS scavengers) with 50 nM PMA. ROS production was measured by 573 
monitoring luminol (50 µM) luminescence in the presence of 1.2U/ml horseradish 574 
peroxidase [85]. 575 
 576 
Mice 577 
Mouse breeding, infections and isolation of peritoneal neutrophils were approved by 578 
the Berlin state authority Landesamt für Gesundheit und Soziales. Animals were bred 579 
at the Max Planck Institute for Infection Biology. Mice were housed in specific pathogen 580 
free (SPF) conditions, maintained on a 12-hour light/dark cycle and fed ad libitum.  581 
NE -/- [86], NE/PR3 -/- [87] and DNase 1 -/- [88] mice were previously described. PAD4  582 
-/- mice [89] were a kind gift of Denisa Wagner.   583 
 584 
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Mouse neutrophil isolation and stimulation 585 
Murine neutrophils were isolated from peritoneal cavities after elicitation with casein 586 
(Sigma) and centrifugation over Percoll as previously described [90].  587 
Cells were seeded onto glass coverslips at 105/well in 24 well plates in RPMI (Gibco) 588 
containing penicillin/streptomycin (Gibco) and glutamine (Gibco), 1% murine DNase 1 589 
-/- serum and 100 ng/ml murine G-CSF (Peprotech). After 30 min equilibration and 15 590 
min TNF priming, cells were stimulated with 100 nM PMA or 20 µM heme. NETs were 591 
quantified after 15 hours stimulation as described below. 592 
 593 
Quantification of NET formation 594 
 595 
The quantification of NETosis was carried out as previously described [91]. Briefly, 596 
cells were fixed for 30 minutes at room temperature in 2 % paraformaldehyde (PFA), 597 
permeabilized with 0.5 % Triton-X100 and blocked for 30 minutes in blocking buffer. 598 
Cells were then stained with the anti-neutrophil elastase antibody (Calbiochem 599 
481001, 1:200) and an antibody directed against the nucleosomal complex of Histone 600 
2A, Histone 2B and chromatin (PL2/3; 1 ug/ml) [92], as well as the secondary 601 
antibodies goat anti-mouse Alexa Fluor 568 (1:500), goat anti-rabbit Alexa Fluor 488 602 
(1:500) and Hoechst 33342 (Sigma-Aldrich). Samples were mounted on coverslips 603 
with Mowiol. Image acquisition was done using a Leica DMR upright fluorescence 604 
microscope equipped with a Jenoptic B/W digital microscope camera and analyzed 605 
using ImageJ/FIJI software. 606 
 607 
Heme preparation 608 
Heme for in vitro stimulation of neutrophils and for standard curve was prepared fresh 609 
on the day of the experiment. A 10 mM stock solution was prepared by dissolving 610 
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0.0325 g Hemin (H651-9, Frontier Scientific) in 5 ml DMSO. An intermediate 1:10 611 
dilution in PBS was made before stimulating the cells. 612 
 613 
Quantification of plasma heme  614 
 615 
Heme was quantified using the formic acid assay [93]. Briefly, samples were diluted 616 
1:50 in H2O in white 96 well plates. The heme concentration was determined after the 617 
addition of 100% formic acid (150 µL/well, Merck) to all samples and absorbance 618 
measurement at 405nm using a microplate reader. Measurements were compared to 619 
a hemin standard curve in the range of 0.25 – 16 µM in H2O.  620 
 621 
P. falciparum culture 622 
P. falciparum parasites were cultured using standard procedures as described 623 
previously [94] . Parasites were grown at 5% hematocrit in RPMI 1640 medium, 0.5% 624 
AlbuMax II (Invitrogen), 0.25% sodium bicarbonate, and 0.1 mg/ml gentamicin. 625 
Cultures were incubated at 37°C in an atmosphere of 5% oxygen, 5% carbon dioxide, 626 
and 90% nitrogen.  627 
 628 
Trophozoite and merozoite preparation 629 
A  late stage P. falciparum culture was washed and taken up in 2 ml of RPMI and 630 
layered onto 5 ml of a 60% Percoll solution. The mixture was centrifuged at 2000 xg 631 
for 20 minutes at 20ºC and trophozoites were collected at the interphase between 632 
RPMI and Percoll, while uninfected RBCs and ring stage infected RBCs were pelleted. 633 
Parasites were washed three times with RPMI and iRBCs were pelleted. For merozoite 634 
isolation iRBCs were lysed with 0.03 % saponin solution. Subsequently the sample 635 
was washed three times with PBS and taken up in RPMI. Concentration of merozoites 636 
was determined by use of a Neubauer chamber. 637 
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 638 
Isolation of digestive vacuoles from P. falciparum  639 
Late trophozoite cultures with 10 % parasitemia were allowed to complete  schizogony 640 
and reinfection. Cultures were stratified on a discontinuous Percoll-mannitol gradient  641 
and expelled digestive vacuoles collected on the 10/40 % Percoll interphase as 642 
described [95]. The collected interphase was passed through a 27 G needle and 643 
separated by density using 42 % Percoll. The intact DVs could be  collected as dark-644 
grey colored bottom fraction. DVs were resuspended in uptake buffer (pH 7.4, 2mM 645 
MgSO4, 100 mM KCl, 25 mM HEPES, 25 mM NaHCO3 and 5mM Na3PO4), washed 646 
and used in subsequent experiments. 647 
 648 
P. chabaudi infections, plasma and tissue preparation  649 
Male mice aged 8-15 weeks were infected by intravenous injection of viable P. 650 
chabaudi AS parasites (WT) or PccASluc (luciferase-expressing; [45]). To ensure 651 
viability of the parasites, a frozen aliquot was thawed and injected intraperitoneally into 652 
a transfer mouse. The number of asexual parasites intravenously injected into each 653 
mouse was adjusted according to body weight so that every animal received 1x104 654 
iRBCs per 20 grams. Parasitemia was monitored from day 5 post infection every 48 655 
hours by Giemsa-stained thin blood smear. Anti-GCSF antibody (150 µl per mouse, 656 
R&D) or isotype control (150 µl per mouse, R&D) were injected intravenously on day 657 
7 post infection. 658 
Mice were bled by cardiac puncture under non-recovery deep anesthesia.  Blood was 659 
kept from coagulating by addition of 50 µM final concentration of EDTA (Sigma). 660 
Plasma was generated by centrifugation at 10,000 x g at 4°C for 10 minutes. Plasma 661 
was aliquoted, snap frozen in liquid nitrogen and stored at -80°C until further use. 662 
Plasma was always thawed on ice. 663 
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 Organs were harvested without additional perfusion (except in parasite sequestration 664 
experiments) as blood was removed by terminal bleeding of the animals.  The organs 665 
were fixed for 20h at room temperature in 2% PFA.  666 
 667 
Immunohistochemistry 668 
 669 
The blinded scoring of liver pathology as well as the counting of parasites sequestered 670 
in the microvasculature of the livers was performed by trained pathologists at the 671 
iPATH-Berlin Core Unit for immunopathology of experimental model organisms from 672 
H&E stained Paraffin sections of 1 µm thickness. 673 
The scores were defined as follows: 674 
Hepatitis (Malaria) 
   
The following score sheet was modified from [96]. Each of the scored findings was judged 
individually and assigned a score. The value plotted for each animal is the sum of all 
individual scores.  
 
      
Histopathologic 
changes 
Histopathologic grading 
  
0 1 2 3   
Fatty change No fatty change < 10% 10-50% > 50%   
Kupffer 
cells/HPF < 20/HPF 20-35/HPF 36-50/HPF > 50/HPF   
Portal tract 
inflammation 
< 5% of 
portal tract 
area 
5-15% of 
portal tract 
area 
16-30% of 
portal tract 
area 
> 30% of 
portal tract 
area   
Bile duct 
proliferation 
No 
proliferation 
Mild 
proliferation 
Moderate 
proliferation 
Severe 
proliferation   
Sinusoid 
congestion 
No 
congestion 
Mild 
congestion 
Moderate 
congestion 
Severe 
congestion   
Haemozoin 
deposition 
No 
deposition 
Mild 
deposition 
Moderate 
deposition 
Severe 
deposition   
Necrosis none <10% 11-25% >25%   
 675 
 676 
 677 
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Acute Lung injury 678 
The following score sheet was modified from [97]. Animals were assigned to 679 
individual categories matching their histopathological signs. 680 
 681 
 682 
0: thin and delicate alveolar septae, no intra-alveolar fibrin 
strands or hyaline membranes and <5 intra-alveolar cells, no 
perivascular or peribronchial infiltrates 
1: mildly congested alveolar septae, few fibrin strands or hyaline 
membranes and <10 intra-alveolar cells with mild perivascular 
and/or peribronchial infiltration 
2: moderately congested alveolar septae, some fibrin strands or 
hyaline membranes, <20 intra-alveolar cells with moderate 
perivascular and/or  
peribronchial infiltration 
3: severely congested alveolar septae, many fibrin strands and 
presence of hyaline membranes, >20 intra-alveolar cells with 
severe perivascular and/or peribronchial infiltration 
 683 
 684 
Immunofluorescence of mouse tissue sections 685 
 686 
Mouse tissue were fixed in 2% paraformaldehyde solution in Tris-buffered saline (TBS, 687 
pH 7.4) for 20 hours at room temperature. The tissue was then dehydrated and 688 
paraffin-embedded (60°C) using a Leica TP 1020 tissue processor.  689 
Paraffin blocks were cut to 3 μm and sections were mounted and dried on Superfrost 690 
Plus slides (Thermo Scientific) avoiding temperatures above 37°C. After dewaxing and 691 
rehydration, sections were incubated in HIER buffer pH6 (citrate buffer) [20 minutes at 692 
96°C in a steam cooker (Braun)]. 693 
After antigen retrieval, sections were left in the respective HIER buffer at room 694 
temperature to cool below 30°C, rinsed three times with deionized water and once with 695 
PBS pH 7.4, and permeabilized for five minutes with 0.5% Triton-X100 in PBS at room 696 
temperature, followed by three rinsing steps with PBS. 697 
Sections were surrounded with PAP-pen and treated with blocking buffer for 30 698 
minutes to prevent non-specific binding. Primary antibodies were diluted in blocking 699 
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buffer and incubated on the sections overnight at room temperature. The following 700 
primary antibodies were used for tissue sections: anti-mouse-ICAM (AF796, Novus 701 
Biologicals, dilution 1:200), anti-mouse-Calgranulin (MPIIB, in house [5], dilution 1:50) 702 
and anti-CD36 (NB400-144, Novus, 1:200). We used secondary antibodies raised in 703 
donkey and pre-absorbed against serum proteins from multiple host species (Jackson 704 
Immuno Research). Dilution and blocking was done in PBS supplemented with 1% 705 
BSA, 2% donkey normal serum, 5% cold water fish gelatin, 0.05% Tween 20 and 706 
0.05% Triton X100. 707 
Slides were mounted using Mowiol and digitized with a ZEISS AxiosScan.Z1. This is 708 
an automated microscope that generates a series of overlapping photographs which 709 
are assembled to a single image of a complete organ section, in an operator 710 
independent manner. The relative abundance of CalgA (neutrophils), ICAM-1 or CD36 711 
was then calculated by normalizing the respective pixels to the DAPI pixels (total tissue 712 
area), using the software package Volocity 6.3. 713 
 714 
Determination of liver enzyme concentration in mouse plasma  715 
 716 
The concentration of the hepatocyte specific enzyme aspartate-aminotransferase in 717 
the plasma of experimental animals were determined by the routine veterinarian 718 
service laboratory at SYNLAB.vet GmbH (Berlin, Germany). 719 
 720 
FACS analysis of mouse whole blood  721 
100 µl of mouse whole blood were stained directly by addition of 100 µl of FACS 722 
antibodies diluted 1:100 in FACS buffer (PBS supplemented with 2.5 % FCS and 0.1 723 
% NaN3) for 30 minutes. Cells were treated with 3 ml 1-Step Fix/Lyse (00-5333-54, 724 
eBioscience) for 60 min at room temperature, washed once as per manufacturer’s 725 
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instructions and taken up in 250 µl FACS buffer prior to analysis using a MACSQuant 726 
Analyser.  727 
Antibodies were all from BD Biosciences: V500 anti-CD45 (561487), FITC anti-728 
CD3(561798), PE anti-CD115 (565249), PerCP-Cy5.5 anti-Ly6G/C (561103). 729 
Neutrophils were defined as CD45+, CD115-, Ly6G/C+. 730 
 731 
Assessment of sequestration of luciferase-expressing parasites 732 
Mice were infected with a luciferase-expressing strain of P. chabaudi (PccASluc [45]) 733 
as described above but kept on a reverse light cycle, as sequestration occurs during 734 
the dark cycle [45]. At the time of maximum sequestration (12.00 – 14.00 h coordinated 735 
universal time (UCT), reverse light) mice were sacrificed and perfused systemically by 736 
injection of 10 ml PBS into the heart. Organs were harvested and 0.1 g of tissue was 737 
transferred to a Precellys homogenizer tube in PBS and dissociated for one cycle, 10 738 
seconds at 4500 rpm in a Precellys Evolution Homogenizer. The sample was then 739 
diluted 1:10 in PBS, and an equal volume (100 µL) of Bright-Glo substrate (Promega) 740 
was added. Luciferase activity was measured after 2 min incubation using a Perkin 741 
Elmer VICTOR X Light Multilabel Plate Reader. 742 
 743 
Injection of exogenous NETs and control chromatin 744 
 745 
Murine NETs were prepared from WT peritoneal neutrophils with PMA as described 746 
above, washed three times with PBS to remove residual PMA, scraped from the plate 747 
and sonicated for 15 seconds at 70% Power using a Bandelin SONOPLUS sonicator. 748 
DNA concentration was quantified by PicoGreen assay (P11496, Thermo Fisher 749 
Scientific) or NanoDrop measurements . For removal of DNA, the sample was then 750 
treated with 2 U DNase1 from TURBO DNA-free Kit (AM1907, ThermoFisher 751 
Scientific) overnight at 37°C. The kit was chosen because it contains a DNase 752 
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inactivating agent, which was used according to manufacturer’s specifications to 753 
ensure that no DNase activity was introduced into injected mice. Complete digestion 754 
of DNA was confirmed both by agarose gel electrophoresis and PicoGreen 755 
measurement. Mice were injected with an amount of NETs and chromatin previously 756 
observed to have accumulated in infected WT mice, which was 300 ng/ml of blood. 757 
We assumed a blood volume of an adult male mouse of 1.5 ml and therefore injected 758 
450 ng of either NETs or chromatin into each mouse. 759 
 760 
Control chromatin was isolated from bone marrow derived macrophages, which were 761 
prepared according to standard protocol [98].  Chromatin was prepared as previously 762 
described [99]. Briefly, when cells were confluent they were harvested, washed and 763 
counted. 300 µl of hypotonic buffer A (10 mM HEPES, pH 7.5, 10 mM KCl, 3 mM NaCl, 764 
3mM MgCl2, 1 mM EDTA, mM EGTA and 2 mM dithiothreitol and a general protease 765 
inhibitor cocktail (78430, ThermoFisher Scientific)) was added per 5x106 cells and 766 
incubated on ice for 15 minutes. Subsequently 0.05 volumes of 10 % Nonidet P-40 767 
were added, the cells were vortexed and centrifuged at 500 x g for 10 minutes at 4°C. 768 
The supernatant was discarded, the nuclei in the pellet washed in buffer A and 769 
subsequently resuspended in 50 µl of ice-cold buffer NE (20 mM HEPES, pH 7.5, 25 770 
% glycerol, 0.8 mM KCl, 1mM MgCl2, 1 % Nonidet P-40, 05. mM EDTA, 2 mM 771 
dithiothreitol). Following a 20 minutes incubation on ice with occasional mixing the 772 
samples were centrifuged at 14,000 x g for 15 minutes at 4°C. The supernatant was 773 
discarded and the pellet containing the chromatin resuspended in ddH2O. Chromatin 774 
concentration was determined by Picogreen assay (see above) and samples were 775 
stored at -80°C. 776 
 777 
Macrophage stimulation with NETs 778 
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Monocytes were isolated by magnetic CD14 positive selection (130-050-201, Miltenyi 779 
Biotec) and differentiated for 7 days into macrophages in RPMI 1640 containing 780 
penicillin/streptomycin, glutamine and 5 ng/ml human MCSF. At the day of the 781 
experiment, 3x106 neutrophils were stimulated for 4 h with 50 nM PMA. The resulting 782 
NETs were washed three times with PBS, harvested by scraping and sonicated. The 783 
NET concentration was determined by Picogreen assay. Macrophages were 784 
stimulated for 12 h with 1 µg/ml isolated NETs, 100 µg/ml hemozoin (Sigma), 2 ng/ml 785 
TNF (Peprotech) or 100 ng/ml LPS from Salmonella (Enzo Life Sciences).  786 
 787 
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Figure 1 1072 
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 1074 
Figure 1: P. falciparum infection induces accumulation of NETs in circulation  1075 
Circulating NET components (NE/DNA complexes) measured by ELISA in plasma from 1076 
patients in three different malaria cohorts: (A) mixed age uncomplicated malaria (n=43) and 1077 
healthy controls in Gabon (n=9), (B) pediatric uncomplicated (n=10) and severe malaria (n=23) 1078 
patients in Gabon and (C) adult uncomplicated (n=28) and severe malaria (n=27) patients in 1079 
Mozambique.  (D) Quantification of NETosis in neutrophils isolated from healthy individuals 1080 
and malaria patients. (E) H&E images of a) retinopathy positive CM cases showing extensive 1081 
sequestration (arrows) of parasites on the retinal endothelium. Mature parasites appear as 1082 
black dots due to hemozoin pigment accumulated in their food vacuole. b) Retinopathy 1083 
negative CM case showing no sequestration in the vasculature (arrowheads point to the 1084 
capillaries). Scale bar = 50μm. (F) Merged images stained with citrullinated histone H3 (green), 1085 
elastase (red) and DAPI (blue). Arrows indicate NETs, visualized by co-localization of all the 1086 
stained components. Arrowheads point to the capillaries of retinopathy negative cases which 1087 
show no sequestration. Scale bar = 25 μm. Figure shows representative images from 9 1088 
different ‘true’ CM and 8 different ‘faux’ CM cases. (G) 3D reconstruction of capillary with very 1089 
high sequestration, by z-stack images collected from a true CM case. Merged image with 1090 
citrullinated histone H3 (green), elastase (red), and DAPI (blue). DAPI stains the parasite DNA 1091 
inside the parasitized erythrocytes (arrows) as well as the nuclei of the host cells. Data is 1092 
presented as the mean ± standard error of the mean (SEM). Asterisks indicate significance: 1093 
*P<.05, **P<.01, ***P<.001 by Welch’s t-test. 1094 
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Figure 2 1101 
 1102 
 43 
Figure 2: Heme induces NETs in a mechanism requiring serine proteases 1103 
(A) In vitro stimulation of neutrophils isolated from healthy individuals (n=3) with malaria 1104 
associated PAMPs and DAMPs (n = 3). (B - D) Spearman correlation of NETs and heme 1105 
concentration in malaria patients of all three cohorts presented in Fig. 1. (E) Quantification of 1106 
NETosis of healthy neutrophils in response to plasma (10% v/v) from malaria patients, PMA 1107 
(50 nM) or heme (20 μM) in combination with TNF priming. Hx refers to treatment with 70 µM 1108 
hemopexin for 30 min prior to stimulation. (F) Quantification of NETosis in neutrophils from 1109 
healthy donors (n=3) and CGD patients (n=3) in response to PMA and heme. (G) 1110 
Quantification of NETosis in response to PMA and heme in neutrophils from healthy donors 1111 
(n=3) preincubated with inhibitors at the following concentrations: 1 μM Go6983 (PKCi), 30 1112 
uM pyrochatecol, 1 μg/ml cycloheximide, 2.5 μM abemaciclib (CDK6i), 10 μM BB-Cl-1113 
amideine (PAD4i) and 20 μM GW311616A (NEi) . (H) Quantification of NET formation in 1114 
mouse peritoneal neutrophils (n = 3) in response to PMA (100 nM) and heme (20 μM) with 1115 
TNF pretreatment. (F-H): all graphs display mean ± SEM. (I) Representative images used for 1116 
mouse NET quantifications, showing staining for DNA (blue) and histone H2A/H2B-DNA 1117 
(red). Scale bars = 20 μm. Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 by 1118 
Welch’s t-test. 1119 
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Figure 3 1121 
 1122 
 1123 
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 45 
Figure 3: Extracellular NET components are associated with disease severity.  1127 
ELISA quantifications of (A) NETs (MPO/DNA complexes) and (B) extracellular nucleosomes, 1128 
in plasma over the course of a P. chabaudi infection. (C) Parasitemia from Giemsa stained 1129 
blood smears. (D) Representative livers of experimental animals showing severe discoloration 1130 
in infected WT animals. (E) Blinded pathology scores of livers and (F) concentration of 1131 
aspartate aminotransferase (AST) in plasma. n = 5-6 (indicated under the graphs). Data is 1132 
presented as mean ± SEM. Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 and 1133 
****P<0.0001 by two-way analysis of variance (ANOVA) comparison of 3 groups. Color of the 1134 
asterisks indicate which genotype they refer to. (G) AST in plasma of experimental animals 1135 
treated as indicated, at peak parasitemia. n = 6-10. Data is presented as mean ± SEM. 1136 
Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by Mann-1137 
Whitney test. 1138 
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Figure 4 1140 
 1141 
 1142 
 1143 
 1144 
 1145 
 47 
Figure 4: NET components induce emergency granulopoiesis and GCSF production.  1146 
(A) Microscopic quantification of neutrophil liver infiltrates using immunofluorescence for 1147 
calgranulin A. Data is presented as calgranulin A signal (neutrophils) normalized to DAPI 1148 
(total liver area). (B) Ratio of neutrophils to leukocytes determined by FACS analysis of 1149 
whole blood samples. Neutrophils were defined as CD45+, CD3-, Ly6G/C high, CD115-. (C) 1150 
GCSF in supernatants of human macrophages (n=5) stimulated for 12 h with NETs (1 µg/ml), 1151 
LPS (500 ng/ml), TNF (2 ng/ml) and/or hemozoin (100 µg/ml). (D) Plasma GCSF 1152 
concentration. n = 6 for all in vivo data. Data is presented as mean ± SEM. Asterisks indicate 1153 
significance: A,B and D: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by two-way analysis of 1154 
variance (ANOVA) comparison of 3 groups. Color of the asterisks indicate which genotype 1155 
they refer to. (E) Plasma GCSF concentration at peak parasitemia in experimental animals 1156 
receiving indicated treatments. n = 6-10 (indicated by number of dots). Data is presented as 1157 
mean ± SEM. Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 1158 
by Mann-Whitney test. 1159 
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Figure 5 1161 
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Figure 5: NETs promote parasite sequestration and endothelial activation.  1163 
(A) Parasite sequestration in different organs measured by quantification of luminescence from 1164 
a luciferase expressing strain of P. chabaudi; n=6 mice. (B) Histological quantification of 1165 
parasites sequestered in the microvasculature of the liver from H&E images; n=6. (C) 1166 
Representative images of immunofluorescence staining of ICAM-1 (red) and DNA (blue) in the 1167 
livers of experimental animals. (D) Quantification of ICAM-1 signal from (C), normalized to 1168 
DAPI (total liver area); n=6. (E) Soluble ICAM-1 in plasma of experimental animals treated as 1169 
indicated; n=8. (F) Immunofluorescence microscopy quantification of CD36 expression in lung 1170 
sections, normalised to DAPI signal (total lung area); n=2-5 (indicated by number of dots). (G) 1171 
CD36 concentration in plasma measured by ELISA (n=8). Data is presented as mean ± SEM. 1172 
Asterisks indicate significance. D: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by two-way 1173 
analysis of variance (ANOVA) comparison of 3 groups. Color of the asterisks indicate which 1174 
genotype they refer to. E-G: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by Mann-Whitney 1175 
test. 1176 
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Figure 61191 
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Figure 6: GCSF neutralisation is protective in malaria.  1196 
(A) Parasitemia of infected mice (n=10) measured by counting thin blood smears. (B) Absolute 1197 
counts of circulating neutrophils determined by FACS. Neutrophils were labelled with an anti-1198 
Ly6G antibody (n=10). (C) NETs (MPO/DNA complexes) in plasma quantified by ELISA 1199 
(n=10). (D) Neutrophil liver infiltrates quantified by analysis of calgranulin A 1200 
immunofluorescence in liver sections (n=6). (E) Parasite sequestration in the liver (n=10), 1201 
measured by luminescence quantification of a luciferase expressing strain of P. chabaudi. (F) 1202 
Concentration of AST in plasma of mice at peak parasitemia (n = 10). Data is presented as 1203 
mean ± SEM, each dot represents one biological replicate. Asterisks indicate significance: 1204 
*P<.05, **P<.01, ***P<.001 and ****P<0.0001 by Kruskall-Wallis test (G) GCSF concentration 1205 
in plasma of uncomplicated malaria patients (n=43) and healthy individuals (n=9) in Gabon. 1206 
Data is presented as the mean ± SEM. Asterisks indicate significance: *P<.05, **P<.01, 1207 
***P<.001 by Welch’s t-test. 1208 
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Figure S1 1222 
 52 
 1223 
Supplementary Figure 1: In vitro stimulations of human neutrophils  1224 
(A) Confocal microscopy images of TNF primed neutrophils stimulated with malaria associated PAMPs 1225 
and DAMPs; PMA serves as a positive control. Scale bars represent 20 µm. (B) IL-8 ELISA of 1226 
supernatants from neutrophils treated with LPS. IL-8 is not stored in the neutrophil and its release 1227 
requires translation. (C) Production of ROS measured by luminol assay (D) Production of ROS by 1228 
neutrophils treated with pyrocatechol. Cells are unable to produce ROS in response to both PMA or 1229 
heme.(E) Quantification of NET formation induced by PMA or heme in healthy human neutrophils 1230 
pretreated with the indicated ROS scavenging agents at the following concentrations: 30 µM 1231 
Pyrochatecol, 10 mM N-acetyl-l-cysteine. 10 µM MitoTempo, 10 ng/µl Catalase & 10 ng/µl SOD-1. Data 1232 
is presented as the mean ± SEM.  1233 
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Figure S2: 1235 
 1236 
Supplementary Figure 2: Necrosis and sequestration in the livers of P. chabaudi infected mice.  1237 
(A) Sample images of H&E stained liver sections used to quantify liver damage. Black outlines indicate 1238 
areas containing necrotic liver cells, large arrows indicate immune cell infiltration and yellow outlines 1239 
indicated healthy tissue surrounded by necrosis. Analysis was performed blinded by a pathologist, scale 1240 
bar equals 100 µm. (B) Representative H&E stained images of livers from infected animals, arrows 1241 
indicate iRBCs bound to the endothelium, scale bar equals 20 µm. (C) Electron micrograph of an 1242 
infected red blood cell attached to the vasculature in the liver of a WT mice.  1243 
 1244 
Figure S3 1245 
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 1249 
 1250 
Figure S3: Pathology in the lungs of P. chabaudi infected animals. Blinded scoring of lungs from 1251 
infected animals at peak parasitemia, according to score sheet presented in Methods. 1252 
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 1270 
 1271 
Figure S4: Parasitemia of NET fragment injected mice. Parasitemia of infected animals quantified 1272 
by counting Giemsa stained thin blood smears.  1273 
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Figure S5: 1286 
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 1287 
Figure S5: Immunofluorescence images used to quantify neutrophils in livers of infected mice. 1288 
Sample images of livers from infected animals of indicated genotypes stained with Hoechst (blue) and 1289 
a neutrophil specific anti-Calgranulin A antibody (red). 1290 
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Figure S6 1293 
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 1295 
 1296 
Figure S6: Quantification of free circulating heme in plasma of uninfected and infected animals, 1297 
treated with a GCSF neutralizing antibody or isotype control antibody. 1298 
 1299 
  1300 
 59 
 1301 
Table S1: Patient information of cohort 1 & 2 in Gabon.  1302 
 1303 
 1304 
 Cohort 1 Cohort 2 
   uncomplicated uncomplicated severe 
n 43 10 23 
  Mean (min - max) 
Age (years) 1 (1 - 84) 4 (3 - 7) 4 (1 - 10) 
Parasitemia (pf/µl) 
1635 (59 - 
260113) 
7595 (2100 - 
20000) 
335743 (2600 - 
1100000 
Temperature (°C) 38 (37 - 40) n.a. n.a. 
Hematocrit (%) 
33.45 (19.2 - 
44.9) n.a. n.a. 
Hemoglobin (g/dl) 
10.1 (4.2 - 
17.7) 10.1 (9.1 - 12.2) 8.76 (5 - 13.2) 
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Table S2: Clinical characteristics of the patient population in Mozambique.  1340 
 1341 
 Uncomplicated malaria Severe malaria 
n 28 27 
 Mean 
(min-max) 
% 
proportion 
Mean 
(min – max) 
%  
proportion 
Age 36 (18-73)  42 (20-65)  
Sex (females)  35.7 (10/28)  44.4 (12/27) 
Hb 11.7 (5.9-15.7)  10.8 (3.2-17.0)  
WBC 6.1 (2.2-12.4)  7.5 (1.3-15.5)  
Platelets 119 (24-324)  127 (11-452)  
Creatinine 108 (57-203)  152 (72-357)  
Se-glucosis 9.0 (4.2-34.2)  9.0 (3.7-40.5)  
Systolic BP 123 (90-240)  119 (70-160)  
Respiratory 
rate 
20 (14-28)  25 (16-68)  
Liver failurea)  0  11.1 (3/27) 
Coagulat. 
disturb.b) 
 0  3.7 (1/27) 
Cerebral 
disturb.c) 
 14.3 (4/28)  29.6 (8/27) 
Case fatality 
rate 
 0d)  3.7 (1/27) 
a)Defined as jaundice and/or bilirubine>43µmol/L 1342 
b)Defined as bleeding disturbaces and/or hemolysis 1343 
c)Defined as Glascow Coma Scale≤11, repeated convulsions and/ or confusion       1344 
d) Two patients missing 1345 
Continuous variables given in mean (min-max), not rounded numbers. 1346 
 1347 
 1348 
 1349 
 1350 
 1351 
 1352 
 1353 
 1354 
 1355 
 1356 
 1357 
 1358 
 1359 
 1360 
 1361 
 1362 
 1363 
 61 
Table S3 Clinical diagnosis and classification of subjects whose ocular tissue was used 1364 
for immunofluorescence experiments. 1365 
 1366 
Sample Before post-mortem clinical 
diagnosis 
Post-mortem 
classification 
Retinopathy 
1 Clinical CM 1 Yes 
2 Clinical CM 1 Yes 
3 Clinical CM 1 Yes 
4 Clinical CM 1 Yes 
5 Clinical CM 1 Yes 
6 Clinical CM + SMA 2 Yes 
7 Clinical CM 2 Yes 
8 Clinical CM, severe pneumonia, 
severe meningoencephalitis 
2 Yes 
9 Clinical CM 2 Yes 
10 Clinical CM – pneumonia,  Reye's 
syndrome 
3 No 
11 Clinical CM, likely cause of death is 
anaemia 
3 No 
12 Clinical CM + SMA, hepatitis 3 No 
13 Clinical CM; Severe pneumonia 3 No 
14 Clinical CM, severe pneumonia with 
spread to meninges 
3 No 
15 Clinical CM, left ventricular failure 
with pulmonary oedema 
3 No 
16 Clinical CM, fatal pneumonia 3 No 
17 Salmonella  sepsis 7 No 
 1367 
Class 1 & 2 (CM1 & 2) are the “true CM” while Class 3 (CM3) are the “Faux CM”. CM3 mimics CM 1368 
during life so these children are control for being really sick and for premorbid events but in fact there is 1369 
no sequestration and there is an alternative cause of death – suggesting a different pathogenic process 1370 
- so they represent an excellent comparator for sequestration driven pathology.  Class 7= Non-malarial 1371 
encephalopathy, infectious. SMA, severe malarial anaemia.  1372 
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